Your browser doesn't support javascript.
loading
CXD101 and nivolumab in patients with metastatic microsatellite-stable colorectal cancer (CAROSELL): a multicentre, open-label, single-arm, phase II trial.
Saunders, M P; Graham, J; Cunningham, D; Plummer, R; Church, D; Kerr, R; Cook, S; Zheng, S; La Thangue, N; Kerr, D.
Afiliação
  • Saunders MP; The Christie NHS Foundation Trust, Manchester, UK. Electronic address: mark.saunders8@nhs.net.
  • Graham J; The Beatson West of Scotland Cancer Centre, Glasgow, UK.
  • Cunningham D; The Royal Marsden NHS Foundation Trust, London, UK.
  • Plummer R; The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK.
  • Church D; The Churchill Hospital Oxford University Hospitals NHS Trust, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK.
  • Kerr R; The Churchill Hospital Oxford University Hospitals NHS Trust, Oxford, UK.
  • Cook S; Celleron Therapeutics Limited, Oxford, UK.
  • Zheng S; Celleron Therapeutics Limited, Oxford, UK.
  • La Thangue N; Celleron Therapeutics Limited, Oxford, UK.
  • Kerr D; The Churchill Hospital Oxford University Hospitals NHS Trust, Oxford, UK; Celleron Therapeutics Limited, Oxford, UK.
ESMO Open ; 7(6): 100594, 2022 12.
Article em En | MEDLINE | ID: mdl-36327756
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Nivolumabe Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Nivolumabe Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article